Related Experiment Video
Updated: Jul 20, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
"Chip"ping away at heart failure.
J David Barrans1, Choong-Chin Liew
1Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Methods in Molecular Medicine
|August 26, 2006
Summary
This study used a custom microarray, the CardioChip, to analyze gene expression in human heart failure. Researchers identified specific genes, including those for sarcomeric proteins, that show altered expression in failing hearts, offering insights into cardiovascular disease mechanisms.
Area of Science:
- Cardiovascular research
- Molecular biology
- Genomics
Background:
- Microarray technology enables exploration of molecular mechanisms in complex diseases.
- Cardiovascular diseases, especially heart failure with unknown causes, benefit from molecular profiling.
- Gene expression analysis is crucial for understanding disease pathology.
Purpose of the Study:
- To investigate gene expression profiles in human heart failure using a specialized microarray.
- To identify differentially expressed genes associated with heart failure.
- To assess the utility of custom microarrays in cardiovascular disease research.
Main Methods:
- Development and utilization of a 10,000+ element cardiovascular complementary DNA microarray (CardioChip).
- Comparison of gene expression profiles between failing human hearts and nonfailing controls.
- Identification of gene panels associated with heart failure.
Main Results:
- Differential expression of genes encoding sarcomeric proteins, cytoskeletal proteins, stress proteins, and Ca2+ regulators was observed in heart failure.
- The CardioChip successfully identified distinct molecular signatures in failing hearts.
- Specific gene panels were highlighted as potential biomarkers or therapeutic targets.
Conclusions:
- Microarrays, particularly the CardioChip, are effective tools for dissecting the molecular landscape of cardiovascular diseases like heart failure.
- The identified gene expression patterns provide insights into the pathophysiology of heart failure.
- This approach facilitates the examination of molecular portraits in cardiovascular disease conditions.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...